InMed Pharmaceuticals Inc... (INM)
NASDAQ: INM
· Real-Time Price · USD
2.32
-0.02 (-0.85%)
At close: Aug 15, 2025, 3:59 PM
2.32
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT
InMed Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Net Income | -6.38B | -7.91M | -6.82M | -7.68M | -6.08M | -6.35M | -6.97M | -7.95M | -15.48M | -16.96M | -19.14M | -18.6M | -13.99M | -13.61M | -11.58M | -10.2M | -8.9M | -7.37M | -7.34M |
Depreciation & Amortization | 403.79M | 302.24K | 599.83K | 604.22K | 603.33K | 602.11K | 596.85K | 596K | 293K | -7.17K | 21.35K | -98.63K | 82.04K | 260.48K | 121.42K | 120.87K | 140.18K | 148K | 157.25K |
Stock-Based Compensation | 92.62M | 94.26K | 141.49K | 137.71K | 139.24K | 134.29K | 186.67K | 278.15K | 414.56K | 559.29K | 703.43K | 697.89K | 741.86K | 754.07K | 635.93K | 610.19K | 631.89K | 646.32K | 510.32K |
Other Working Capital | 46.43K | -24.45M | -24.61M | 22.46K | 755.15K | 738.5K | -318.68K | -286.81K | -1.24M | -2.85M | -1.34M | -1.18M | -54.22K | -227.19K | -434.47K | -490.65K | -1.39M | 663.45K | 512.76K |
Other Non-Cash Items | -111.05M | -1.82B | -1.82B | 396.68K | -7.17M | -7.89M | -7.76M | -7.76M | 5.13M | 5.32M | 5.06M | 5.07M | 57.65K | -131.25K | 378.21K | 374.23K | 388.76K | 392.12K | 24K |
Deferred Income Tax | n/a | n/a | 169.43K | 264.38K | 7.9M | 7.9M | 7.73M | 7.64M | 108.37K | 178.17K | 189.3K | 190.56K | 82.84K | 12.5K | -241.26K | -242.39K | -240.08K | -244.31K | -1.67K |
Change in Working Capital | 1.04M | 616.12K | -421.29K | n/a | -1.3M | -737.8K | -983.1K | -666.72K | -1.66M | -3.9M | -2.47M | -2.71M | -443.77K | -86.55K | -391.64K | -450.45K | -1.41M | 577.7K | 490.27K |
Operating Cash Flow | -5.99B | -7.32M | -1.83B | -7.02M | -6.64M | -6.34M | -7.2M | -7.28M | -10.61M | -14.23M | -15.05M | -15.45M | -13.47M | -12.81M | -11.07M | -9.79M | -9.39M | -5.85M | -6.16M |
Capital Expenditures | 9.29K | 9.22K | n/a | n/a | -42.9K | -171.02K | -161.8K | -161.8K | -128.12K | -3.23K | -3.23K | -3.23K | -3.3K | n/a | n/a | n/a | -1.11K | -6.78K | -9.41K |
Cash Acquisitions | n/a | n/a | n/a | n/a | -118.45K | 371.92K | -118.45K | -118.45K | 90.78K | -399.59K | 90.78K | 90.78K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -40.04M | -20.92K | -21.34M | -42.07K | -84.66K | -63.31K | -63.48K | -42.16K | -421.36K | -421.36K | -421.36K | -421.36K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 40.04M | 20.92K | 21.34M | 42.07K | 84.66K | 63.31K | 63.48K | 42.16K | -90.97K | -91.55K | -91.55K | -91.55K | -581.43 | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -8.93K | -8.93K | -9K | -9K | 118.38K | -371.99K | -381.55K | -381.55K | -797.88K | -307.51K | 8.13K | -241.87K | 54.29K | 54.29K | -251.72K | -1.73K | 135.28K | -166.86K | -116.17K |
Investing Cash Flow | 362.46 | 291.00 | -9K | -9K | -42.97K | -171.09K | -661.8K | -661.8K | -1.35M | -1.22M | -417.22K | -667.22K | 50.4K | 54.29K | -251.72K | -1.73K | 134.17K | -173.64K | -125.57K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 395.69K | 366.38K | 366.38K | 366.38K | -29.31K | n/a | n/a | -21.64K | -47.16K | -68.09K | -100.54K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.1B | -249.04K | 837.21M | 175.00 | -654 | -23.04K | 548.22K | -23.04K | -512.93K | -490.54K | -1.9M | -2.44M | -2.05M | -2.47M | -2.69M | -1.62M | -1.54M | -1.15M | -97.93K |
Financial Cash Flow | 4.1B | 1.21M | 842.93M | 4.69M | 4.69M | 4.59M | 5.25M | 10.68M | 15.67M | 15.64M | 9.49M | 14.94M | 9.87M | 14.01M | 21.8M | 10.85M | 10.9M | 6.81M | -177.35K |
Net Cash Flow | 3.68B | -993.7M | -988.74M | -2.34M | -2M | -1.92M | -2.61M | 2.74M | 3.71M | 172.61K | -5.99M | -1.19M | -3.56M | 1.26M | 10.85M | 1.56M | 2.47M | 861.96K | -6.63M |
Free Cash Flow | -7.81B | -1.83B | -1.83B | -7.02M | -6.69M | -6.51M | -7.36M | -7.45M | -10.74M | -14.24M | -15.06M | -15.45M | -13.47M | -12.81M | -11.07M | -9.79M | -9.39M | -5.85M | -6.17M |